Vanqua Bio closes $85 million Series B financing

Silverstein Foundation Announces Grant Funding to AcureX Therapeutics.

2021.08.31-Silverstein-Foundation-AcureX-Therapeutics-PRDownload

Prevail Therapeutics Acquired by Lilly

Prevail Announces First Patient Dosed

Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001

Aspen Neuroscience Announces $70 Million Series A Financing